Computational Model for Hyperfibrinolytic Onset of Acute Traumatic Coagulopathy.

Area of Science:

• Biomedical Engineering
• Computational Biology
• Trauma Research

Background:

• Acute traumatic coagulopathy (ATC) is a severe complication in trauma patients, leading to increased hemorrhage and mortality.
• The precise mechanisms underlying the onset of ATC remain largely unknown.
• Understanding ATC is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of fibrinolysis, specifically tissue-plasminogen activator (t-PA) release, in the development of ATC.
• To explore how vessel geometry and injury extent influence local coagulopathy through hyperfibrinolysis.
• To simulate the efficacy of tranexamic acid (TXA) in treating t-PA-induced coagulopathy.

Main Methods:

• Development and application of a partial differential equation model.
• Simulation of fibrinolysis profiles across different vessel sizes and injury extents.
• Modeling the impact of tranexamic acid treatment on t-PA-mediated coagulopathy.

Main Results:

• The model demonstrates that variable t-PA release in different vessel sizes can lead to localized coagulopathy via hyperfibrinolysis, explaining clinical observations.
• Simulations successfully reproduced the time-sensitive efficacy of tranexamic acid treatment.
• The study highlights the critical role of vessel geometry and injury severity in modulating fibrinolytic responses.

Conclusions:

• Hyperfibrinolysis, driven by t-PA release, is a plausible mechanism for the early onset of acute traumatic coagulopathy.
• Tranexamic acid treatment efficacy is significantly dependent on the timing of administration.
• This computational approach provides valuable insights into ATC pathophysiology and treatment strategies.